Citigroup Inc Grifols Sa Transaction History

Citigroup Inc

$153 Billion
Q2 2024

A detailed history of Citigroup Inc transactions in Grifols Sa stock. As of the latest transaction made, Citigroup Inc holds 168,326 shares of GRFS stock, worth $1.38 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

168,326

Previous 1,275 13102.04%

Holding current value

$1.38 Million

Previous $8,000 13150.0%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$6.27 - $7.7 $1.05 Million - $1.29 Million	167,051 Added 13102.04%	168,326 $1.06 Million
Q1 2024 May 10, 2024	SELL	$5.47 - $11.38 $1.78 Million - $3.7 Million	-325,079 Reduced 99.61%	1,275 $8,000
Q4 2023 Feb 09, 2024	BUY	$7.71 - $11.56 $7,725 - $11,583	1,002 Added 0.31%	326,354 $3.77 Million
Q3 2023 Nov 09, 2023	SELL	$8.91 - $10.91 $6,424 - $7,866	-721 Reduced 0.22%	325,352 $2.97 Million
Q2 2023 Aug 10, 2023	BUY	$7.14 - $9.29 $1,627 - $2,118	228 Added 0.07%	326,073 $2.99 Million
Q1 2023 May 11, 2023	SELL	$6.65 - $10.69 $228,307 - $367,009	-34,332 Reduced 9.53%	325,845 $2.4 Million
Q4 2022 Feb 09, 2023	SELL	$5.96 - $8.53 $1.79 Million - $2.57 Million	-301,174 Reduced 45.54%	360,177 $3.06 Million
Q3 2022 Nov 10, 2022	BUY	$5.95 - $14.3 $1.11 Million - $2.66 Million	185,973 Added 39.12%	661,351 $4.08 Million
Q2 2022 Aug 10, 2022	BUY	$10.6 - $13.28 $1.57 Million - $1.96 Million	147,763 Added 45.1%	475,378 $5.65 Million
Q1 2022 May 12, 2022	SELL	$10.37 - $12.73 $4.12 Million - $5.06 Million	-397,371 Reduced 54.81%	327,615 $3.83 Million
Q4 2021 Feb 10, 2022	SELL	$10.21 - $15.27 $1.94 Million - $2.91 Million	-190,499 Reduced 20.81%	724,986 $8.14 Million
Q3 2021 Nov 10, 2021	BUY	$14.07 - $17.3 $12.9 Million - $15.8 Million	915,485 New	915,485 $13.4 Million

Others Institutions Holding GRFS

# of Institutions

147

Shares Held

151M

Call Options Held

2.38M

Put Options Held

662K

View Full List

About Grifols SA

Ticker GRFS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 678,910,976
Market Cap $5.57B
Description
Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...

More about GRFS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Account